跳至主要内容
临床试验/ACTRN12612001287820
ACTRN12612001287820终止2 期

Prospective, open-label, randomised, multicentre, pilot clinical trial involving about 700 stroke survivors to (a) explore the feasibility of recruitment and likely level of support required to uptake the intervention; (b) to inform the power calculation, identify the inclusion criteria and best primary outcome measure for conducting a full-scale randomised controlled trial; and (c) to assess preliminary efficacy of a DVD-based observational learning intervention in stroke survivors for improving their functional outcomes at 3 months after randomisation.

ational Institute for Stroke & Applied Neurosciences, AUT University0 个研究点目标入组 700 人开始时间: 2012年12月12日最近更新:
适应症

试验速览

阶段
2 期
状态
终止
发起方
入组人数
700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 o limit(—)
性别
All

入选标准

  • All consecutive patients with stroke admitted to participating centers will be potentially eligible for inclusion in the study if they meet all the following inclusion criteria: (1) clinically diagnosed stroke with some level of disability; (2) discharged home; and (3) availability of home DVD-player. All such patients and their informal (unpaid) caregiver (next of kin or the person providing most day-to-day support, whenever available) will be approached couple days before or after their discharge to home but no later than 9 months after the stroke onset.

排除标准

  • inability to communicate (including non-fluent English), history of previous disabling stroke (pre-stroke MRS 3-5), living outside the study area, admission to hospital from a residential care facility or rest home, inability to provide informed consent, participation in another clinical trial, significant cognitive impairment that would affect their understanding of the instructions and compliance with the intervention (by opinion of the treating physician or rehabilitation specialist at the time of the interview), or history of alcoholism, drug abuse, or serious mental illness (e.g. depression, psychosis, bipolar disorder).

研究者

发起方
ational Institute for Stroke & Applied Neurosciences, AUT University

相似试验

进行中(未招募)
3 期
A clinical trial to study the effects of two drugs, R-TPR-026 andAranesp® in patients for correction of anemia due to Chronic Kidney Disease
CTRI/2013/09/004005Reliance Life sciences Pvt Ltd104
进行中(未招募)
3 期
A clinical trial to study the effects of two drugs, R-TPR-023 and Avastinâ?¢ in patients with Metastatic colorectal cancer
CTRI/2013/05/003699Reliance Life sciences Pvt Ltd105
进行中(未招募)
3 期
A clinical trial to study the effects of two drugs, R-TPR-016 and Herceptin® in patients with Metastatic HER2-Overexpressing Breast Cancer
CTRI/2013/04/003549Reliance Life sciences Pvt Ltd
进行中(未招募)
1 期
Prospective, randomized, multicenter, open label, phase II / III study to assess efficacy and safety of ranibizumab 0.5 mg intravitreal injections plus panretinal photocoagulation (PRP) versus PRP in monotherapy in the treatment of subjects with high risk proliferative diabetic retinopathy. (PROTEUS)
EUCTR2013-003640-23-GBAIBILI - Association for Innovation and Biomedical Research on Light and Image94
进行中(未招募)
1 期
Prospective, randomized, multicenter, open label, phase II / III study to assess efficacy and safety of ranibizumab 0.5 mg intravitreal injections plus panretinal photocoagulation (PRP) versus PRP in monotherapy in the treatment of subjects with high risk proliferative diabetic retinopathy. (PROTEUS)
EUCTR2013-003640-23-PTAIBILI - Association for Innovation and Biomedical Research on Light and Image94